HYBRID EVENT: You can participate in person at Amsterdam, Netherlands or Virtually from your home or work.

Michael R Mitcheff

 

Michael R Mitcheff

Michiana Neuroscience,
United States of America

Abstract Title: Autism spectrum: Electrical Epileptiform Condition. Integration of functional neuropsychological testing and EEG neurofeedback/anticonvulsants future treatment. Overlap ASD, ADD, ADHD, Tourette’s, PTSD, Dyslexia

Biography:

Dr. Michael R Mitcheff has a Doctor of Psychology (Psy.D.) degree with specialization in Clinical Neuropsychology & Psychopharmacology. He completed his Pre-Doctoral and Behavioral Health Residency at Franciscan St. James Hospitals and Medical Centers. Dr. Mitcheff completed 2-year post-doctoral fellowship in Clinical Neuropsychology at Diamond Headache Unit at St. Joseph Hospital in Chicago. He is Owner and Director of Neuropsychology & Neuropsychiatry at Michiana Neuroscience. He oversees his company’s contracts in hospitals, acute rehab, sub-acute rehab and assisted living. Michael focuses upon clinical work and sees patients based upon complexity/need. Not ability to pay. Dr. Mitcheff also teaches neuropsychologists in training.

Research Interest:

Autism spectrum disorder (ASD) is a neurological and developmental disorder. An abnormal EEG occurs in about 2-4% of the general population. 70-80% of those with autism have abnormal EEG. Estimated 40% of ASD diagnosed clonic tonic seizures (generalized). It appears isolated Gamma with multi-focal heavy hertz wavelength oscillations often occur. Those with ASD often have unique gifts valuable to society. ASD can be multifocal with parietal lobe stimulation and perceptual pattern recognition. The categorization/synthesis pattern recognition is most evident on Block Design scores on the WAIS-IV/WISC-5. This pattern recognition is highly useful to society. This allows focus upon future thought processes. Every strength is weakness so perceptual/sensory overstimulation is a strong challenge for the spectrum. Autism “stimming” appears to be a way of grounding the parietal lobe and perceptual overstimulation. Stimming appears to be a type of neurofeedback self-regulation, but it is not clear what impact this has upon EEG. Psychoanalytically, stimming in ASD appears a form of reaction formation along with undoing defense mechanisms. Treatments: Neurofeedback has demonstrated unique ability to treat neurological and mental health conditions. Medications largely treat symptoms, however medications like Lamictal (lamotrigine) do focus upon underlying biochemical etiologies. Lamictal is largely a glutamate and aspartate antagonist. This has proved an important treatment tool. This appears to relax CNS and PNS. This has also been shown to be neuroprotective protecting the nerve from excitotoxicity and cell loss. Lamictal is used heavy in mental health heavy and valuable tool.